Anti-SARS-CoV-2 biotherapeutics and chemotherapeutics: An insight into product specifications and marketing dynamics
Chemotherapeutics and biotherapeutics agents have been explored as a potential treatment
for COVID-19. This study was aimed to elucidate latest update related to biotherapeutics and …
for COVID-19. This study was aimed to elucidate latest update related to biotherapeutics and …
Current therapeutics for COVID-19, what we know about the molecular mechanism and efficacy of treatments for this novel virus
D Narayanan, T Parimon - International journal of molecular sciences, 2022 - mdpi.com
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has caused significant
morbidity and mortality worldwide. Though previous coronaviruses have caused substantial …
morbidity and mortality worldwide. Though previous coronaviruses have caused substantial …
COVID-19: An Update on the Latest Therapeutic Agents
The COVID-19 pandemic has plagued the world for over three years since discovering the
causative virus, SARS-CoV-2, in China. The rampant spread of the virus led to the loss of …
causative virus, SARS-CoV-2, in China. The rampant spread of the virus led to the loss of …
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs
GEDA Abuo-Rahma, MFA Mohamed, TS Ibrahim… - RSC …, 2020 - pubs.rsc.org
The global outbreak of COVID-19 viral infection is associated with the absence of specific
drug (s) for fighting this viral infection. About 10 million people are already infected, about …
drug (s) for fighting this viral infection. About 10 million people are already infected, about …
Drugs intervention study in COVID-19 management
Abstract By 9 February 2021, the Coronavirus has killed 2,336,650 people worldwide and it
has been predicted that this number continues to increase in year 2021. The study aimed to …
has been predicted that this number continues to increase in year 2021. The study aimed to …
A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2
Coronavirus, known as the coronavirus pandemic, is continuing its spread across the world,
with over 42 million confirmed cases in 189 countries and more than 1.15 million deaths …
with over 42 million confirmed cases in 189 countries and more than 1.15 million deaths …
COVID-19 infection: targeting possibilities for treatment
The outbreak of novel coronavirus (nCoV) or severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2) in December 2019 in Wuhan, China, has posed an international public …
2 (SARS-CoV-2) in December 2019 in Wuhan, China, has posed an international public …
Emerging therapeutic approaches to combat COVID-19: present status and future perspectives
K Vivekanandhan, P Shanmugam… - Frontiers in Molecular …, 2021 - frontiersin.org
Coronavirus disease (COVID-19) has emerged as a fast-paced epidemic in late 2019 which
is disrupting life-saving immunization services. SARS-CoV-2 is a highly transmissible virus …
is disrupting life-saving immunization services. SARS-CoV-2 is a highly transmissible virus …
Present and future treatment strategies for coronavirus disease 2019
E Elekhnawy, AA Kamar, F Sonbol - Future journal of pharmaceutical …, 2021 - Springer
Background The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in
many challenges to the healthcare organizations around the world. Unfortunately, until now …
many challenges to the healthcare organizations around the world. Unfortunately, until now …
A global picture: therapeutic perspectives for COVID-19
VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …